Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Behind the Robot's Smiles and Frowns: In Social Context, People Do Not Mirror Android's Expressions But React to Their Informational Value.

Hofree G, Ruvolo P, Reinert A, Bartlett MS, Winkielman P.

Front Neurorobot. 2018 Apr 24;12:14. doi: 10.3389/fnbot.2018.00014. eCollection 2018.

2.

The Face of Distaste: A Preliminary Study.

Chapman HA, Lee DH, Susskind JM, Bartlett MS, Anderson AK.

Chem Senses. 2017 Jul 1;42(6):457-463. doi: 10.1093/chemse/bjx024.

PMID:
28486601
3.

Objective, computerized video-based rating of blepharospasm severity.

Peterson DA, Littlewort GC, Bartlett MS, Macerollo A, Perlmutter JS, Jinnah HA, Hallett M, Sejnowski TJ.

Neurology. 2016 Nov 15;87(20):2146-2153. Epub 2016 Oct 21.

4.

Automated decoding of facial expressions reveals marked differences in children when telling antisocial versus prosocial lies.

Zanette S, Gao X, Brunet M, Bartlett MS, Lee K.

J Exp Child Psychol. 2016 Oct;150:165-179. doi: 10.1016/j.jecp.2016.05.007. Epub 2016 Jun 16.

PMID:
27318957
5.

Automated Assessment of Children's Postoperative Pain Using Computer Vision.

Sikka K, Ahmed AA, Diaz D, Goodwin MS, Craig KD, Bartlett MS, Huang JS.

Pediatrics. 2015 Jul;136(1):e124-31. doi: 10.1542/peds.2015-0029. Epub 2015 Jun 1.

6.

Nonlinear dynamics of the CAM circadian rhythm in response to environmental forcing.

Hartzell S, Bartlett MS, Virgin L, Porporato A.

J Theor Biol. 2015 Mar 7;368:83-94. doi: 10.1016/j.jtbi.2014.12.010. Epub 2014 Dec 24.

PMID:
25542971
7.

Classification and Weakly Supervised Pain Localization using Multiple Segment Representation.

Sikka K, Dhall A, Bartlett MS.

Image Vis Comput. 2014 Oct 1;32(10):659-670.

8.

Bridging the mechanical and the human mind: spontaneous mimicry of a physically present android.

Hofree G, Ruvolo P, Bartlett MS, Winkielman P.

PLoS One. 2014 Jul 18;9(7):e99934. doi: 10.1371/journal.pone.0099934. eCollection 2014.

9.

Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.

Nanayakkara NP, Tekwani BL, Herath HM, Sahu R, Gettayacamin M, Tungtaeng A, van Gessel Y, Baresel P, Wickham KS, Bartlett MS, Fronczek FR, Melendez V, Ohrt C, Reichard GA, McChesney JD, Rochford R, Walker LA.

Antimicrob Agents Chemother. 2014 Aug;58(8):4737-44. doi: 10.1128/AAC.02674-13. Epub 2014 Jun 9.

10.

Training facial expression production in children on the autism spectrum.

Gordon I, Pierce MD, Bartlett MS, Tanaka JW.

J Autism Dev Disord. 2014 Oct;44(10):2486-98. doi: 10.1007/s10803-014-2118-6.

PMID:
24777287
11.

Automatic decoding of facial movements reveals deceptive pain expressions.

Bartlett MS, Littlewort GC, Frank MG, Lee K.

Curr Biol. 2014 Mar 31;24(7):738-43. doi: 10.1016/j.cub.2014.02.009. Epub 2014 Mar 20.

12.

Multilayer Architectures for Facial Action Unit Recognition.

Tingfan Wu, Butko NJ, Ruvolo P, Whitehill J, Bartlett MS, Movellan JR.

IEEE Trans Syst Man Cybern B Cybern. 2012 Aug;42(4):1027-38. doi: 10.1109/TSMCB.2012.2195170. Epub 2012 May 11.

PMID:
22588611
13.

Airborne spread of Pneumocystis jirovecii.

Bartlett MS, Lee CH.

Clin Infect Dis. 2010 Aug 1;51(3):266. doi: 10.1086/653934. No abstract available.

14.

Rearrangement of the RNA polymerase subunit H and the lower jaw in archaeal elongation complexes.

Grünberg S, Reich C, Zeller ME, Bartlett MS, Thomm M.

Nucleic Acids Res. 2010 Apr;38(6):1950-63. doi: 10.1093/nar/gkp1190. Epub 2009 Dec 29.

15.

Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.

Nanayakkara NP, Ager AL Jr, Bartlett MS, Yardley V, Croft SL, Khan IA, McChesney JD, Walker LA.

Antimicrob Agents Chemother. 2008 Jun;52(6):2130-7. doi: 10.1128/AAC.00645-07. Epub 2008 Mar 31.

16.

Face recognition by independent component analysis.

Bartlett MS, Movellan JR, Sejnowski TJ.

IEEE Trans Neural Netw. 2002;13(6):1450-64. doi: 10.1109/TNN.2002.804287.

17.

Transcription factor E is a part of transcription elongation complexes.

Grünberg S, Bartlett MS, Naji S, Thomm M.

J Biol Chem. 2007 Dec 7;282(49):35482-90. Epub 2007 Oct 5.

18.

Image statistics of American Sign Language: comparison with faces and natural scenes.

Bosworth RG, Bartlett MS, Dobkins KR.

J Opt Soc Am A Opt Image Sci Vis. 2006 Sep;23(9):2085-96.

PMID:
16912735
19.

Human and computer recognition of facial expressions of emotion.

Susskind JM, Littlewort G, Bartlett MS, Movellan J, Anderson AK.

Neuropsychologia. 2007 Jan 7;45(1):152-62.

PMID:
16765997
20.

Determinants of transcription initiation by archaeal RNA polymerase.

Bartlett MS.

Curr Opin Microbiol. 2005 Dec;8(6):677-84. Epub 2005 Oct 24. Review.

PMID:
16249119
21.

Topography of the euryarchaeal transcription initiation complex.

Bartlett MS, Thomm M, Geiduschek EP.

J Biol Chem. 2004 Feb 13;279(7):5894-903. Epub 2003 Nov 13.

22.

Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.

Lasbury ME, Durant PJ, Bartlett MS, Smith JW, Lee CH.

Clin Diagn Lab Immunol. 2003 Mar;10(2):293-302.

23.

Production and role of nitric oxide in the alveolar immune response to Pneumocystis carinii.

Lasbury ME, Tang X, Durant PJ, Bartlett MS, Smith JW, Lee CH.

J Eukaryot Microbiol. 2001;Suppl:165S-166S. No abstract available.

PMID:
11906046
24.

Alteration in expression of the rat mitochondrial ATPase 6 gene during Pneumocystis carinii infection.

Asnicar MA, Henegariu O, Shaw MM, Goheen MP, Bartlett MS, Smith JW, Lee CH.

BMC Microbiol. 2001;1:8. Epub 2001 Jun 29.

25.

Internal transcribed spacer regions of rRNA genes of Pneumocystis carinii from monkeys.

Hsueh JY, Bohm RP Jr, Didier PJ, Tang X, Lasbury ME, Li B, Jin S, Bartlett MS, Smith JW, Lee CH.

Clin Diagn Lab Immunol. 2001 May;8(3):503-8.

26.

Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis carinii.

Ball MD, Bartlett MS, Shaw M, Smith JW, Nasr M, Meshnick SR.

Antimicrob Agents Chemother. 2001 May;45(5):1473-9.

27.

Characterization of the gene encoding a histidine and aspartic acid-rich protein from Pneumocystis carinii.

Lee CH, Lasbury ME, Paulsrud JR, Bauer NL, Brady SL, Weinberg GA, Durant PJ, Bartlett MS, Smith JW.

J Eukaryot Microbiol. 2000 Nov-Dec;47(6):581-4.

PMID:
11128711
28.

The orientation of DNA in an archaeal transcription initiation complex.

Bartlett MS, Thomm M, Geiduschek EP.

Nat Struct Biol. 2000 Sep;7(9):782-5.

PMID:
10966650
29.

Down-regulation of GATA-2 transcription during Pneumocystis carinii infection.

Tang X, Lasbury ME, Davidson DD, Bartlett MS, Smith JW, Lee CH.

Infect Immun. 2000 Aug;68(8):4720-4.

30.

Engines of gene expression.

Geiduschek EP, Bartlett MS.

Nat Struct Biol. 2000 Jun;7(6):437-9. No abstract available.

PMID:
10881183
32.

Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: a blinded comparison to standard methods.

Torres J, Goldman M, Wheat LJ, Tang X, Bartlett MS, Smith JW, Allen SD, Lee CH.

Clin Infect Dis. 2000 Jan;30(1):141-5.

PMID:
10619742
33.

Typing of Histoplasma capsulatum isolates based on nucleotide sequence variation in the internal transcribed spacer regions of rRNA genes.

Jiang B, Bartlett MS, Allen SD, Smith JW, Wheat LJ, Connolly PA, Lee CH.

J Clin Microbiol. 2000 Jan;38(1):241-5.

34.

Recombinant major surface glycoprotein of Pneumocystis carinii elicits a specific immune response but is not protective in immunosuppressed rats.

Lasbury ME, Angus CW, Klivington D, Durant PJ, Bartlett MS, Smith JW, Lee CH.

J Eukaryot Microbiol. 1999 Sep-Oct;46(5):136S-137S. No abstract available.

PMID:
10519289
35.

Mouse derived Pneumocystis carinii in an axenic culture system.

Lasbury ME, Goheen MP, Durant PJ, Bartlett MS, Smith JW, Lee CH.

J Eukaryot Microbiol. 1999 Sep-Oct;46(5):120S-121S. No abstract available.

PMID:
10519277
36.

Ability of Pneumocystis carinii cysts to seed cultures and infect animals.

Lasbury ME, Goheen MP, Durant PJ, Bartlett MS, Smith JW, Lee CH.

J Eukaryot Microbiol. 1999 Sep-Oct;46(5):118S-119S. No abstract available.

PMID:
10519276
37.

Classifying Facial Actions.

Donato G, Bartlett MS, Hager JC, Ekman P, Sejnowski TJ.

IEEE Trans Pattern Anal Mach Intell. 1999 Oct;21(10):974.

38.

Measuring facial expressions by computer image analysis.

Bartlett MS, Hager JC, Ekman P, Sejnowski TJ.

Psychophysiology. 1999 Mar;36(2):253-63.

PMID:
10194972
39.

Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.

Pascale JM, Shaw MM, Durant PJ, Amador AA, Bartlett MS, Smith JW, Gregory RL, McLaughlin GL.

Infect Immun. 1999 Feb;67(2):805-9.

40.
41.

Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure.

Walker DJ, Wakefield AE, Dohn MN, Miller RF, Baughman RP, Hossler PA, Bartlett MS, Smith JW, Kazanjian P, Meshnick SR.

J Infect Dis. 1998 Dec;178(6):1767-75.

PMID:
9815231
42.

Current in vitro culture systems for Pneumocystis.

Atzori C, Aliouat EM, Bartlett MS, Dujardin L, Cargnel A, Dei-Cas E.

FEMS Immunol Med Microbiol. 1998 Sep;22(1-2):169-72. Review.

43.

Determination of copy number of rRNA genes in Pneumocystis carinii f. sp. hominis.

Tang X, Bartlett MS, Smith JW, Lu JJ, Lee CH.

J Clin Microbiol. 1998 Sep;36(9):2491-4.

44.

RNA polymerase mutants that destabilize RNA polymerase-promoter complexes alter NTP-sensing by rrn P1 promoters.

Bartlett MS, Gaal T, Ross W, Gourse RL.

J Mol Biol. 1998 Jun 5;279(2):331-45.

PMID:
9642041
45.

Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.

Kazanjian P, Locke AB, Hossler PA, Lane BR, Bartlett MS, Smith JW, Cannon M, Meshnick SR.

AIDS. 1998 May 28;12(8):873-8.

PMID:
9631140
46.

Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia.

Bartlett MS, Shaw MM, Smith JW, Meshnick SR.

Antimicrob Agents Chemother. 1998 Apr;42(4):934-5.

47.

Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.

Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, Lancaster MV, Pfaller MA, Rex JH, Rinaldi MG, Walsh TJ.

Antimicrob Agents Chemother. 1998 Feb;42(2):282-8.

48.

In vitro and in vivo models of Pneumocystis carinii.

Bartlett MS, Queener SF, Shaw MM, Durant PJ, Lee CH, Smith JW.

J Eukaryot Microbiol. 1997 Nov-Dec;44(6):51S. No abstract available.

PMID:
9508437
49.

Modified 8-aminoquinolines cure mouse Pneumocystis carinii infection.

Shaw MM, McChesney JD, Nanayakkara D, Dias LR, Lee CH, Durant PJ, Ball MD, Smith JW, Bartlett MS.

J Eukaryot Microbiol. 1997 Nov-Dec;44(6):40S. No abstract available.

PMID:
9508428
50.

Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes.

Lee CH, Helweg-Larsen J, Tang X, Jin S, Li B, Bartlett MS, Lu JJ, Lundgren B, Lundgren JD, Olsson M, Lucas SB, Roux P, Cargnel A, Atzori C, Matos O, Smith JW.

J Clin Microbiol. 1998 Mar;36(3):734-41.

Supplemental Content

Loading ...
Support Center